S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

NCT01498289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

213

Enrollment

NETWORK

Sponsor class

Conditions

Adenocarcinoma of the Gastroesophageal Junction
Esophageal Cancer
Gastric Cancer

Interventions

DRUG: FOLFOX regimen
DRUG: docetaxel
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]